Pharma companies were mostly left out of the stock market’s broader rally Monday morning on the news that President Donald Trump will sign an order lowering drug prices.
Category: zepbound
Auto Added by WPeMatico
Eli Lilly is stepping up its fight against copycat weight loss drugs
In its continuing war against copycat drugs, Eli Lilly (LLY) said on Wednesday that it filed suits against four telehealth companies that offer cheaper versions of its blockbuster GLP-1 weight loss drugs Mounjaro and Zepbound.
- Hims & Hers stock slipped as investors were left unimpressed with its new weight-loss drug options
Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed.
Eli Lilly and Novo Nordisk are tackling heart health next
- GLP-1s are driving returns on R&D investments for Big Pharma, report says
Big Pharma is expected to see big returns from its investment in a class of drugs made famous by Novo Nordisk’s (NVO) popular diabetes drug Ozempic.
